Breaking News

J&J, BARDA Expand Alliance for Potential Coronavirus Vaccine

To mobilize resources to rapidly advance the initial stages of Janssen's COVID-19 vaccine development program

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Janssen Pharmaceutical Companies will further expedite its investigational coronavirus vaccine program through an expanded collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health & Human Services. The partnership builds on Johnson & Johnson’s response to the new coronavirus disease (COVID-19) outbreak. In addition to Janssen’s e...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters